Choroidal Neovascularization Clinical Trials
2 recruiting trials for Choroidal Neovascularization. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 2 / Phase 3NCT04704921
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in...
ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular degeneration (wet AMD or nAMD)....
Sponsor: AbbVieEnrolling: 63020 locations
RECRUITINGNCT07002372
Effect of Video Viewing on Intravitreal Injection Experience
Study Objective The goal of this clinical trial is to evaluate whether viewing a procedural video can improve the patient experience and reduce the incidence and severity of...
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEnrolling: 1821 location